3
Announcements
Trials
Browse
Landscape
Phase
Phase 2/3
1
Status
Recruiting
1
Sponsor Class
OTHER
6
OTHER_GOV
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
Conditions
Breast Neoplasms
45
Neoplasms
27
Uterine Cervical Neoplasms
24
Prostatic Neoplasms
21
Carcinoma, Non-Small-Cell Lung
20
Colorectal Neoplasms
19
Stomach Neoplasms
18
Carcinoma, Hepatocellular
16
Multiple Myeloma
14
Ovarian Neoplasms
11
Recurrence
10
Pancreatic Neoplasms
10
Esophageal Squamous Cell Carcinoma
10
Esophageal Neoplasms
9
Leukemia, Myeloid, Acute
8
Endometrial Neoplasms
8
Lymphoma
7
Lung Neoplasms
7
Brain Neoplasms
7
Liver Neoplasms
6
Leukemia
6
Disease
6
Carcinoma, Ovarian Epithelial
6
Triple Negative Breast Neoplasms
5
Small Cell Lung Carcinoma
5
Rectal Neoplasms
5
Papillomavirus Infections
5
Colonic Neoplasms
5
Urinary Bladder Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
OTHER_GOV
×
Cytokine Release Syndrome
×
Clear all
NCT07502118
2026-03-30
NexCAR19
Health Institutes of Turkey
Phase 2/3
Recruiting
40 enrolled